Page last updated: 2024-11-06
estriol and Aneuploid
estriol has been researched along with Aneuploid in 21 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy." | 7.72 | Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003) |
| " To evaluate the efficacy of screening for detection of aneuploid pregnancy in this age group, the serum samples of 34 women who underwent amniocentesis and who had confirmed fetal aneuploidy were assayed for alpha-fetoprotein (AFP), hCG, and unconjugated estriol (E3)." | 7.68 | Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. ( Canick, JA; Heyl, PS; Miller, W, 1990) |
| "To determine the association between second-trimester serum Down syndrome screening (alpha-fetoprotein [AFP] free beta-human chorionic gonadotropin [b-hCG] unconjugated estriol [uE3]) and preterm birth and to create predictive models for preterm birth." | 3.91 | Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study. ( Luewan, S; Nunthapiwat, S; Sekararithi, R; Sirichotiyakul, S; Srisupundit, K; Tongprasert, F; Tongsong, T; Wanapirak, C, 2019) |
| "Our study suggest that in patients with hereditary thrombophilia a new correction factor should be used, when calculating unconjugated estriol MoM value, which is one of the markers of second trimester aneuploidy screening test." | 3.81 | The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers. ( Baser, E; Cicek, MN; Cıkman, DI; Cıkman, MS; Karslı, MF; Seckin, KD, 2015) |
| "To evaluate if levels of pregnancy-associated plasma protein-A (PAPP-A), free β-hCG and nuchal translucency (NT) used in first trimester aneuploidy screening and α-fetoprotein (AFP), unconjugated oestriol (UE3) and free β-hCG in the second trimester are altered in pregnancies with human immunodeficiency virus (HIV) infection." | 3.77 | First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection. ( Spencer, K, 2011) |
| " All patients had a first-trimester nuchal translucency scan, and those without cystic hygroma had a combined test (nuchal translucency, pregnancy-associated plasma protein A, and free beta-hCG) and returned at 15-18 weeks for a second-trimester quadruple screen (serum alpha-fetoprotein, total hCG, unconjugated estriol, and inhibin-A)." | 3.74 | First- and second-trimester screening: detection of aneuploidies other than Down syndrome. ( Berkowitz, RL; Bianchi, DW; Breathnach, FM; Carr, SR; Comstock, CH; Craigo, SD; Cuckle, HS; D'Alton, ME; Dugoff, L; Klugman, S; Lambert-Messerlian, G; Malone, FD; Nyberg, DA; Porter, TF; Saade, GR; Timor-Tritsch, IE; Tripp, T; Wolfe, HM, 2007) |
| "To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy." | 3.72 | Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003) |
| "to review the contribution of unconjugated estriol in Down's syndrome detection, and influence of maternal age, cut-off choice, and population specificity on the balance between triple-marker test sensitivity and specificity." | 3.70 | The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. ( Huderer-Duric, K; Kuvacic, I; Rubala, D; Skrablin, S; Sonicki, Z; Suchanek, E, 2000) |
| "Data from 24,504 patients who had biochemical screening for Down syndrome by single (alpha-fetoprotein), double (alpha-fetoprotein, beta-human chorionic gonadotropin), or triple screening (alpha-fetoprotein, beta-human chorionic gonadotropin, unconjugated estriol) who had complete outcome information were analyzed by (1) existing gaussian-based methods, (2) the Glasgow ratio method, and (3) a new statistical approach (i." | 3.69 | MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs. ( Ager, JW; Ayoub, M; Chik, L; Chin, B; Dvorin, E; Evans, MI; Johnson, MP; Krivchenia, EL; O'Brien, JE; Sokol, RJ, 1995) |
| "A retrospective evaluation of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated oestriol (uE3) levels in maternal blood in the second trimester was conducted for cases of aneuploid pregnancies identified from a series of women who underwent amniocentesis." | 3.69 | A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. ( Murakami, I; Natori, M; Okada, S; Sato, A; Suzumori, K; Takagi, T; Tanaka, M; Tanemura, M, 1997) |
| " To evaluate the efficacy of screening for detection of aneuploid pregnancy in this age group, the serum samples of 34 women who underwent amniocentesis and who had confirmed fetal aneuploidy were assayed for alpha-fetoprotein (AFP), hCG, and unconjugated estriol (E3)." | 3.68 | Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. ( Canick, JA; Heyl, PS; Miller, W, 1990) |
| "Although the risk for fetal aneuploidy is not altered by obesity, the risk for significant birth defects is increased." | 2.53 | Genetic Screening and the Obese Gravida. ( Rose, NC, 2016) |
| "Missed aneuploidies included trisomy 21, sex chromosome abnormalities, trisomy 13, trisomy 22, and trisomy 18." | 1.29 | Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old. ( Boots, L; Desai, R; DuBard, MB; Owen, J; Wenstrom, KD, 1995) |
| "For the detection of one infant with trisomy 18 that will survive past five months, 25 normal fetuses would be lost owing to amniocentesis." | 1.29 | Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18? ( Donnenfeld, AE, 1995) |
Research
Studies (21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Pierre, CC | 1 |
| Greene, DN | 1 |
| Delaney, S | 1 |
| Lockwood, CM | 1 |
| Peck Palmer, OM | 1 |
| Yamashiro, KJ | 1 |
| Galganski, LA | 1 |
| Hirose, S | 1 |
| Quibel, T | 1 |
| Rozenberg, P | 1 |
| Nunthapiwat, S | 1 |
| Sekararithi, R | 1 |
| Wanapirak, C | 1 |
| Sirichotiyakul, S | 1 |
| Tongprasert, F | 1 |
| Srisupundit, K | 1 |
| Luewan, S | 1 |
| Tongsong, T | 1 |
| Chasen, ST | 1 |
| Cıkman, MS | 1 |
| Seckin, KD | 1 |
| Karslı, MF | 1 |
| Baser, E | 1 |
| Cıkman, DI | 1 |
| Cicek, MN | 1 |
| Rose, NC | 1 |
| Pekarek, DM | 1 |
| Chapman, VR | 1 |
| Neely, CL | 1 |
| Ramsey, PS | 1 |
| Biggio, JR | 1 |
| Dugoff, L | 2 |
| Spencer, K | 1 |
| Hui, D | 1 |
| Okun, N | 1 |
| Murphy, K | 1 |
| Kingdom, J | 1 |
| Uleryk, E | 1 |
| Shah, PS | 1 |
| Duric, K | 1 |
| Skrablin, S | 2 |
| Lesin, J | 1 |
| Kalafatic, D | 1 |
| Kuvacic, I | 2 |
| Suchanek, E | 2 |
| Summers, AM | 1 |
| Farrell, SA | 1 |
| Huang, T | 1 |
| Meier, C | 1 |
| Wyatt, PR | 1 |
| Breathnach, FM | 1 |
| Malone, FD | 1 |
| Lambert-Messerlian, G | 1 |
| Cuckle, HS | 1 |
| Porter, TF | 1 |
| Nyberg, DA | 1 |
| Comstock, CH | 1 |
| Saade, GR | 1 |
| Berkowitz, RL | 1 |
| Klugman, S | 1 |
| Craigo, SD | 1 |
| Timor-Tritsch, IE | 1 |
| Carr, SR | 1 |
| Wolfe, HM | 1 |
| Tripp, T | 1 |
| Bianchi, DW | 1 |
| D'Alton, ME | 1 |
| Wenstrom, KD | 2 |
| Desai, R | 1 |
| Owen, J | 2 |
| DuBard, MB | 1 |
| Boots, L | 2 |
| Donnenfeld, AE | 1 |
| Evans, MI | 1 |
| Chik, L | 1 |
| O'Brien, JE | 1 |
| Chin, B | 1 |
| Dvorin, E | 1 |
| Ayoub, M | 1 |
| Krivchenia, EL | 1 |
| Ager, JW | 1 |
| Johnson, MP | 1 |
| Sokol, RJ | 1 |
| Suzumori, K | 1 |
| Tanemura, M | 1 |
| Murakami, I | 1 |
| Okada, S | 1 |
| Natori, M | 1 |
| Tanaka, M | 1 |
| Takagi, T | 1 |
| Sato, A | 1 |
| Chu, Dc | 1 |
| Huderer-Duric, K | 1 |
| Sonicki, Z | 1 |
| Rubala, D | 1 |
| Heyl, PS | 1 |
| Miller, W | 1 |
| Canick, JA | 1 |
Reviews
4 reviews available for estriol and Aneuploid
| Article | Year |
|---|---|
What you need to know about maternal-fetal medicine.
Topics: alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Congenital Abnormalities; Estriol; Female; F | 2019 |
Maternal serum analyte screening for fetal aneuploidy.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome | 2014 |
Genetic Screening and the Obese Gravida.
Topics: alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Chromosome Disorders; Congenital Abnormaliti | 2016 |
Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Gestational Age | 2012 |
Other Studies
17 other studies available for estriol and Aneuploid
| Article | Year |
|---|---|
Reconsidering the use of race adjustments in maternal serum screening.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Sub | 2023 |
[What are the real purpose and scope of screening for aneuploidy?]
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; DNA; Down S | 2018 |
Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Down | 2019 |
The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Est | 2015 |
Medication effects on midtrimester maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome Disorders; Coh | 2009 |
First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Fetal Gr | 2010 |
First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Case-Control Studies; Chorionic Gonadotropin, bet | 2011 |
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Topics: Abortion, Spontaneous; Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Down Syndrome; | 2003 |
Maternal serum screening in Ontario using the triple marker test.
Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosomes, Huma | 2003 |
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin, beta Subunit, Human; Diagnosis, Diffe | 2007 |
Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome | 1995 |
Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18?
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Brain Diseases; Chorionic Gonadotropin; Choroid Plexus; | 1995 |
MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs.
Topics: Adolescent; Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chorionic Gon | 1995 |
A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Topics: Adult; Algorithms; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Chromosomes, Human, Pair | 1997 |
Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Chorionic Gonadotropin; Chorionic Gonadotropin, beta | 1999 |
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Topics: Adult; Age Factors; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropi | 2000 |
Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
Topics: Adrenal Cortex Hormones; Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Down Syndrom | 1990 |